[Abdominal indwelling central venous catheter in treatment of liver fibrosis and intractable ascites].
OBJECTIVE To explore the effective therapy for liver fibrosis and refractory ascites. A total of 54 cases of liver fibrosis and intractable ascites were randomly divided into an experimental group and a control group. The experimental group received the improved central venous catheter indwelling of intraperitoneal drainage, irrigation, cavity injection, combined with systemic comprehensive treatment. The control group received the routine paracentesis. The total effective rate was 82.1% in the experimental group, and the total effective rate was 57.7% in the control group (Chi(2) = 3.87, P < 0.05). The hospitalization days, abdominal puncture times, ascites significantly effective time were (was) less or shorter in the experiment group compared with those in the control group (P < 0.05). The improved central venous catheter in peritoneal catheter is safe, effective, and convenient in the treatment of hepatic fibrosis and intractable ascites.